Los Angeles, California
VIRTUAL EVENT: Due to concerns brought about by the Covid-19 virus, our conference has been re-scheduled as a VIrtual Event on:
August 1, 2020
This year’s virtual symposium provides a comprehensive update on the prevention, diagnosis and management of heart failure (HF). The program includes lectures presented by experts in the field. The extensive list of topics includes latest information on the management of hyperlipidemia, prevention of HF in patients with diabetes, extensive review of new drugs for the management of chronic HF and pulmonary hypertension, management of electrolyte abnormalities in HF, remote hemodynamic monitoring for prevention of hospitalizations, diagnosis, management of HF with reduced and preserved ejection fraction and the approach to patients with new classification of mid range ejection fraction. The program also includes discussion of new biomarkers, rate versus rhythm control and prevention of stroke in-patients with HF and atrial fibrillation, innovations in electrophysiological device, amyloidosis, percutaneous interventions and surgical revascularization and the value of myocardial viability assessment inpatients with ischemic cardiomyopathy, and transcatheter mitral valve repair for functional mitral regurgitation and COVID-19 and HF. The 2020 program has been designed to provide a high level and clinically relevant update with a goal of improving the care of patients with heart failure.
Contact the conference secretariat with questions.